Discontinuation of denosumab in men with prostate cancer

被引：0
|
作者：
Anne Sophie Sølling
Torben Harsløf
Helle Kongsbak Brockstedt
Bente Langdahl
机构：
[1] Aarhus University Hospital,Department of Endocrinology and Internal Medicine
[2] Silkeborg Regional Hospital,Department of Internal Medicine
来源：
Osteoporosis International | 2023年 / 34卷
关键词：
Bone mineral density; Denosumab; Osteoporosis; Prostate cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：291 / 297
页数：6
相关论文
共 50 条
  • [31] Certainties and Uncertainties About Denosumab Discontinuation
    Tsourdi, Elena
    Zillikens, M. Carola
    CALCIFIED TISSUE INTERNATIONAL, 2018, 103 (01) : 1 - 4
  • [32] Certainties and Uncertainties About Denosumab Discontinuation
    Elena Tsourdi
    M. Carola Zillikens
    Calcified Tissue International, 2018, 103 : 1 - 4
  • [33] Bisphosphonates or denosumab discontinuation and risk of fractures
    Anastasilakis, Athanasios D.
    Yavropoulou, Maria P.
    Makras, Polyzois
    MATURITAS, 2017, 102 : 75 - 75
  • [34] Denosumab to Prevent Disease and Treatment-Related Skeletal Complications in Men with Prostate Cancer. Emerging Evidence
    Smith, Matthew
    BONE, 2010, 46 : S17 - S18
  • [35] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    R B Egerdie
    F Saad
    M R Smith
    T L J Tammela
    J Heracek
    P Sieber
    C Ke
    B Leder
    R Dansey
    C Goessl
    Prostate Cancer and Prostatic Diseases, 2012, 15 : 308 - 312
  • [36] A RESPONDER ANALYSIS OF THE EFFECTS OF DENOSUMAB ON BONE MINERAL DENSITY IN MEN WITH PROSTATE CANCER RECEIVING ANDROGEN DEPRIVATION THERAPY
    Egerdie, Blair
    Smith, Matthew R.
    Tammela, Teuvo L. J.
    Saad, Fred
    Ke, Chunlei
    Goessl, Carsten
    Dansey, Roger
    JOURNAL OF UROLOGY, 2009, 181 (04): : 611 - 611
  • [37] Responder analysis of the effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer
    Egerdie, R. B.
    Saad, F.
    Smith, M. R.
    Tammela, T. L. J.
    Heracek, J.
    Sieber, P.
    Ke, C.
    Leder, B.
    Dansey, R.
    Goessl, C.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2012, 15 (03) : 308 - 312
  • [38] Hypocalcaemia following denosumab in prostate cancer: A clinical review
    Lau, Lik-Hui
    Cliff, Edward R. S.
    Wong, Vanessa
    Wong, Henry
    Torkamani, Niloufar
    Eer, Audrey
    Weickhardt, Andrew
    Grossmann, Mathis
    CLINICAL ENDOCRINOLOGY, 2020, 92 (06) : 495 - 502
  • [39] Prostate Cancer: Protecting the Skeletal System effectively with Denosumab
    Klug, Elke
    AKTUELLE UROLOGIE, 2012, 43 (06) : 397 - 397
  • [40] SEVERE HYPOCALCEMIA DUE TO DENOSUMAB IN METASTATIC PROSTATE CANCER
    Bhutta, U.
    Iqbal, T.
    Haragsim, L.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2014, 62 (02) : 503 - 503
12345